INR 103.99
(4.61%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 58.28 Million INR | 137.18% |
2022 | 141.37 Million INR | 21.03% |
2021 | 116.81 Million INR | 25.86% |
2020 | 92.8 Million INR | 2.92% |
2019 | 90.17 Million INR | 13.59% |
2018 | 79.38 Million INR | 3.61% |
2017 | 76.62 Million INR | 28.51% |
2016 | 59.62 Million INR | -62.58% |
2015 | 159.33 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 117.88 Million INR | 53.28% |
2024 Q2 | 98.3 Million INR | -16.61% |
2023 Q2 | 83.48 Million INR | 4.24% |
2023 Q1 | 80.09 Million INR | 152.72% |
2023 Q3 | 94.83 Million INR | 13.59% |
2023 Q4 | 76.9 Million INR | -18.91% |
2023 FY | 335.32 Million INR | 137.18% |
2022 Q2 | 94.01 Million INR | -3.5% |
2022 Q4 | -151.9 Million INR | -249.14% |
2022 FY | 141.37 Million INR | 21.03% |
2022 Q1 | 97.41 Million INR | 177.39% |
2022 Q3 | 101.85 Million INR | 8.34% |
2021 Q1 | 70.59 Million INR | 179.35% |
2021 FY | 116.81 Million INR | 25.86% |
2021 Q4 | -125.88 Million INR | -264.81% |
2021 Q3 | 76.38 Million INR | -20.21% |
2021 Q2 | 95.72 Million INR | 35.6% |
2020 Q4 | -88.96 Million INR | -229.99% |
2020 Q3 | 68.43 Million INR | 21.35% |
2020 FY | 92.8 Million INR | 2.92% |
2020 Q1 | 56.39 Million INR | 6.5% |
2020 Q2 | 56.39 Million INR | 0.0% |
2019 Q4 | 52.95 Million INR | 0.0% |
2019 FY | 90.17 Million INR | 13.59% |
2019 Q3 | 52.95 Million INR | -25.77% |
2019 Q2 | 71.33 Million INR | 0.0% |
2019 Q1 | 71.33 Million INR | 26.56% |
2018 Q4 | 56.36 Million INR | 0.0% |
2018 FY | 79.38 Million INR | 3.61% |
2018 Q1 | 54.99 Million INR | 0.0% |
2018 Q2 | 54.99 Million INR | 0.0% |
2018 Q3 | 56.36 Million INR | 2.48% |
2017 FY | 76.62 Million INR | 28.51% |
2016 FY | 59.62 Million INR | -62.58% |
2015 FY | 159.33 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | 89.948% |
Ind-Swift Limited | 946.56 Million INR | 93.842% |
Innova Captab Limited | 931.03 Million INR | 93.739% |
Aarti Drugs Limited | 1.16 Billion INR | 95.007% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 98.104% |
Bajaj HealthCare Limited | 985.34 Million INR | 94.085% |
Sakar Healthcare Limited | 204.07 Million INR | 71.439% |
Aurobindo Pharma Limited | 55.65 Billion INR | 99.895% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 97.718% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 97.644% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | 64.07% |
Morepen Laboratories Limited | 1.98 Billion INR | 97.067% |
Sequent Scientific Limited | 2.9 Billion INR | 97.991% |
Wanbury Limited | 978.96 Million INR | 94.046% |
Laurus Labs Limited | 11.9 Billion INR | 99.511% |
Nectar Lifesciences Limited | 932.7 Million INR | 93.751% |
Gufic Biosciences Limited | 1.18 Billion INR | 95.088% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 99.499% |
Alembic Limited | 872.45 Million INR | 93.319% |
Hikal Limited | 4.46 Billion INR | 98.694% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 99.633% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 99.876% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 97.352% |
Themis Medicare Limited | 1.12 Billion INR | 94.823% |
RPG Life Sciences Limited | 1.63 Billion INR | 96.436% |
Lupin Limited | 125.09 Billion INR | 99.953% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 97.216% |
Wockhardt Limited | 8.48 Billion INR | 99.313% |
Vaishali Pharma Limited | 84.02 Million INR | 30.633% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | 86.709% |
NATCO Pharma Limited | 10.05 Billion INR | 99.42% |
Jubilant Pharmova Limited | 14.45 Billion INR | 99.597% |
FDC Limited | 3.49 Billion INR | 98.335% |
Divi's Laboratories Limited | 14.17 Billion INR | 99.589% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 85.867% |
Eris Lifesciences Limited | 4.94 Billion INR | 98.821% |
Windlas Biotech Limited | 1 Billion INR | 94.209% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.962% |
Mankind Pharma Limited | 29.27 Billion INR | 99.801% |
Venus Remedies Limited | 1.91 Billion INR | 96.958% |
ZIM Laboratories Limited | 1.01 Billion INR | 94.246% |
Neuland Laboratories Limited | 2.92 Billion INR | 98.01% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 99.606% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 94.574% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.953% |
Bal Pharma Limited | 555.62 Million INR | 89.509% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.939% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 97.319% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 95.893% |
Shilpa Medicare Limited | 3.33 Billion INR | 98.252% |
Orchid Pharma Limited | 800.77 Million INR | 92.721% |
Albert David Limited | 1.02 Billion INR | 94.32% |
Ajanta Pharma Limited | 30.46 Billion INR | 99.809% |
Hester Biosciences Limited | 908.84 Million INR | 93.587% |
Valiant Laboratories Limited | 138.02 Million INR | 57.771% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 95.845% |
Procter & Gamble Health Limited | 2.99 Billion INR | 98.054% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -310.104% |
Granules India Limited | 10.31 Billion INR | 99.435% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.822% |
Medicamen Biotech Limited | 335.16 Million INR | 82.609% |
Unichem Laboratories Limited | 6.72 Billion INR | 99.133% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | 87.206% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -754.663% |
Medico Remedies Limited | 59.67 Million INR | 2.324% |
Ipca Laboratories Limited | 18.98 Billion INR | 99.693% |
Syncom Formulations (India) Limited | 345.63 Million INR | 83.136% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 97.256% |
Brooks Laboratories Limited | 51.18 Million INR | -13.888% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.908% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.728% |
Suven Life Sciences Limited | 109.75 Million INR | 46.89% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -26.285% |
Strides Pharma Science Limited | 9.16 Billion INR | 99.364% |
Indoco Remedies Limited | 12.06 Billion INR | 99.517% |
Alpa Laboratories Limited | 127.38 Million INR | 54.241% |
Lasa Supergenerics Limited | 291.17 Million INR | 79.982% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 98.106% |